Clinical Evaluation of a Face Wash Containing New Bactericide in Patients with Acne Vulgaris.
スポンサーリンク
概要
- 論文の詳細を見る
A new face wash formulation containing 1% benzalkonium cetyl phosphate as a bactericide was used for thirteen patients with acne vulgaris and tested on the clinical efficiency as well as the patient satisfaction and side effects, in order to compare to a commercial face wash formulated with 0.3% Irgasan<SUP>®</SUP> DP-300, in addition to the new face wash formulation without the bactericide as a control. The new face wash, in which the better clinical efficiency was shown than the control, was found the same in the clinical performance as the commercial face wash. Looking at the patient satisfaction, the new face wash was ranked good in acne control performance as well as the commercial face wash, while the formulation without the bactericide performed poor. On the other hand, the side effects such as irritation and dry skin of the new face wash was higher than the commercial face wash.
- 日本皮膚科学会大阪地方会の論文
日本皮膚科学会大阪地方会 | 論文
- ツベルクリン皮内反応部に出現する浸潤細胞の電顕的観察
- セフメタゾ-ル・ナトリウムによりSystemic eczematous contact-type dermatitis medicamentosaと急性腎不全を生じた1例 (単純化学物質による皮膚障害)
- 歯科金属アレルギ-による全身の扁平苔癬の1例 (接触皮膚炎とパッチテスト-4-)
- Oakmoss Allergyを示すPigmented Cosmetic Dermatitisの1例 (単純化学物質による皮膚障害)
- 漢方薬中のCinnamic系化合物による薬疹の1例 (単純化学物質による皮膚障害) -- (職業性および薬剤性皮膚炎と薬疹)